GW Pharmaceuticals

GW Pharmaceuticals is a biotechnology company based in the UK, known for developing cannabinoid-based medications. They focus on harnessing cannabis compounds, specifically CBD (cannabidiol) and THC (tetrahydrocannabinol), to treat various medical conditions. Their most notable product, Epidiolex, is an FDA-approved medication for epilepsy, aimed at patients with certain types of severe seizures. GW Pharmaceuticals combines scientific research with medicine to explore the therapeutic potential of cannabis, providing new treatment options for patients with chronic illnesses and demonstrating the legitimacy of using cannabis in healthcare.